IRIS
VANGELISTA, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 378
NA - Nord America 220
AS - Asia 167
Totale 765
Salva come PNG Salva come JPEG
Nazione #
IE - Irlanda 330
US - Stati Uniti d'America 218
CN - Cina 164
FI - Finlandia 23
DE - Germania 11
IT - Italia 10
CA - Canada 2
KZ - Kazakistan 2
PL - Polonia 2
SE - Svezia 2
JP - Giappone 1
Totale 765
Salva come PNG Salva come JPEG
Città #
Dublin 330
Ashburn 74
Shanghai 42
Jacksonville 40
Nanjing 38
Helsinki 23
Nanchang 22
Princeton 15
New York 14
Lawrence 13
Hebei 12
Tianjin 10
Washington 10
Shenyang 9
Wilmington 9
Jiaxing 7
Hangzhou 6
Seattle 6
Beijing 5
Changsha 5
Imbersago 5
Medford 4
Phoenix 4
Ann Arbor 3
Chandler 3
West Jordan 3
Astana 2
Borås 2
Calgary 2
Frankfurt am Main 2
Norwalk 2
Orange 2
Warsaw 2
Fuzhou 1
Guangzhou 1
Los Angeles 1
Ningbo 1
Redwood City 1
Rome 1
Santa Clara 1
Tokiwa 1
Zhengzhou 1
Totale 735
Salva come PNG Salva come JPEG
Nome #
The elastic I-band region of titin is assembled in a "modular" fashion by weakly interacting Ig-like domains 31
Bip 1, a monoclonal antibody with specificity for the major birch pollen allergen Bet v 1, modulates IgE binding to the allergen 27
Calcium-binding allergens: From plants to man 27
Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from timothy grass (Phleum pratense) pollen 25
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1 25
Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments - Candidates for a novel form of specific immunotherapy 25
Division of the major birch pollen allergen, Bet v 1, into two non-anaphylactic fragments 24
Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: Candidates for specific immunotherapy 24
Molecular and immunological characterization of carp parvalbumin, a major fish allergen 24
Molecular Characterization of Bip 1, a Monoclonal Antibody That Modulates IgE Binding to Birch Pollen Allergen, Bet v 1 23
Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: Structural basis for calcium-modulated IgE recognition 23
Purification, biochemical, and immunological characterisation of a major food allergen: Different immunoglobulin E recognition of the apo- and calcium-bound forms of carp parvalbumin 21
Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5 19
AllergoOncology – the impact of allergy in oncology: EAACI position paper 18
The immunoglobulin-like modules C epsilon 3 and alpha 2 are the minimal units necessary for human IgE-Fc epsilon RI interaction 18
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer 16
B cell epitopes of the major timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidates for immunotherapy 16
Effects of omalizumab on basophils: Potential biomarkers in asthma and chronic spontaneous urticaria 15
In search of a vaccine for mouse allergy: Significant reduction of mus m 1 allergenicity by structure-guided single-point mutations 15
A minimal receptor-Ig chimera of human FcεRI α-chain efficiently binds secretory and membrane IgE 13
Analysis of the localization of STE6/CFTR chimeras in a Saccharomyces cerevisiae model for the cystic fibrosis defect CFTRΔF508 13
An antitumor cellular vaccine based on a mini-membrane IgE 13
Cutting edge: IgE plays an active role in tumor immunosurveillance in mice 13
AllergoOncology: The role of IgE-mediated allergy in cancer 13
Staphylococcus aureus infection and persistence in chronic rhinosinusitis: Focus on leukocidin ED 13
Functionalized etched tilted fiber Bragg grating aptasensor for label-free protein detection 12
Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity 12
Role of periostin in inflammatory bowel disease development and synergistic effects mediated by the CCL5-CCR5 axis 12
Current progress in the understanding of IgE-FcεRI interaction 12
A molecular model of type I allergy: Identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcεRI interaction and reacts with receptor-bound IgE 12
NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE 12
Editorial: CCR5: A receptor at the center stage in infection 11
A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: Molecular, immunological, and structural characterization of the epitope-containing domain 11
Ultralow Limit Detection of Soluble HER2 Biomarker in Serum with a Fiber-Optic Ball-Tip Resonator Assisted by a Tilted FBG 11
Critical role of the N-loop and β1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity 11
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants 11
Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides 10
AllergoOncology: Microbiota in allergy and cancer—A European Academy for Allergy and Clinical Immunology position paper 10
Calcium-dependent immunoglobulin E recognition of the apo- and calcium- bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7 10
Picomolar detection of thrombin with fiber-optic ball resonator sensor using optical backscatter reflectometry 9
Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses 9
Rational Engineering of a Sub-Picomolar HIV-1 Blocker 9
Membrane immunoglobulins are stabilized by interchain disulfide bonds occurring within the extracellular membrane-proximal domain 9
NON-ANAPHYLACTIC FORMS OF ALLERGENS AND THEIR USE 9
An in vitro model for the Allergen-IgE-FcεRI interaction 9
Unreliable measurement of basophil maximum leukotriene release with the Bühlmann CAST 2000 enzyme-linked immunosorbent assay kit 8
Antitumor IgE adjuvanticity: Key role of FcεRI 8
Ig modules as discrete structural units to exploit functional and structural aspects of Ig-like receptors 8
Rational design of novel HIV-1 entry inhibitors by RANTES engineering 8
IgE as Adjuvant in Tumor Vaccination 8
The expanding therapeutic perspective of CCR5 blockade 8
Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers 8
Structural Studies on the Zinc‐endopeptidase Light Chain of Tetanus Neurotoxin 7
Efficient folding of the FcεRI α-chain membrane-proximal domain D2 depends on the presence of the N-terminal domain D1 7
Membrane IgE binds and activates FcεRI in an antigen-independent manner 7
Role and redirection of IgE against cancer 7
Perspectives on Assembling Coronavirus Spikes on Fiber Optics to Reveal Broadly Recognizing Antibodies and Generate a Universal Coronavirus Detector 7
Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES 7
Molecular characterization, expression in Escherichia coli, and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4 6
Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers 6
Modified microbiota for microbicide drug delivery 6
Filling the Gaps in Antagonist CCR5 Binding, a Retrospective and Perspective Analysis 5
Purification, structural and immunological characterization of a timothy grass (Phleum pratense) pollen allergen, Phl p 4, with cross-reactive potential 5
Totale 831
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.239
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020122 54 58 0 0 0 1 0 0 0 9 0 0
2020/202120 0 0 0 0 0 0 2 9 0 9 0 0
2021/202232 0 0 0 0 0 0 0 1 2 0 10 19
2022/2023409 22 0 0 0 0 0 0 0 376 3 8 0
2023/2024211 23 8 10 20 24 71 31 10 4 8 2 0
Totale 831